NEWS

January 19, 2018

Albireo to Receive More than $55 Million ⁽¹⁾ in Nondilutive Cash Payments

January 8, 2018

Agenus Inc. Announces $230 Million Royalty Monetization with HealthCare Royalty Partners

January 3, 2018

Albireo Announces Royalty Monetization Agreement with HealthCare Royalty Partners for Elobixibat in Japan

November 17, 2017

Acorda Announces Royalty Monetization Transactions for $53 Million

October 26, 2017

FDA Recognizes Orphan Drug Exclusivity for Adamas’ GOCOVRI™

October 1, 2017

Profiles in Leadership – Robert Langer: From an Ugly Duckling to Singular Swan

September 29, 2017

HealthCare Royalty Partners expands U.K. operations

August 24, 2017

Adamas Announces FDA Approval of GOCOVRI™ as First and Only Medication for the Treatment of Dyskinesia in Parkinson’s Disease Patients

August 15, 2017

Portola Pharmaceuticals Announces AndexXa® (Andexanet Alfa) Biologics License Application Resubmission Accepted for Review by U.S. FDA

August 4, 2017

Johnson & Johnson Vision Announces Agreement to Acquire TearScience